Oscient Amends License
Oscient Pharmaceuticals Corp. (OSCI) amended its licensing deal to cover all nations in the European Union. The stock price soared 86 cents to close at $5.06.
posted by FC Market News at 10:53 AM
Friday, December 29, 2006
Previous Posts
- Private Equity Firms Interested In Alltel
- Apple Restates Earnings
- Apple Continues To Fall
- SciClone Applies To Sell Liver Treatment In China
- Positive Test Results For Threshold Pharmaceuticals
- AsiaInfo Will Upgrade China Telecom
- Coverage Initiated On CDC
- First Financial To Join S&P SmallCap 600
- Telik Downgraded
- Revenue Falls For Euro Tech
0 Comments:
Post a Comment
<< Home